The effect of vitamins C, E, D on blood lipids and glucose levels in patients with type 2 diabetes

Evaluation of the effect of oral administration of vitamins C, E, D on blood glucose and lipids levels in patients with type 2 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014071918532N1

Enrollment

160

Registered

2015-03-26

Start date

2014-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes type 2. Non-insulin-dependent diabetes mellitus without complications

Interventions

Intervention 1: vitamin D, oral tablet 50000 unit once weekly, for 6 weeks. Intervention 2: vitamin C, oral tablet 1000 mg daily I, for 6 weeks. Intervention 3: controls, Without intervention. Interve

Treatment - Drugs

vitamin D, oral tablet 50000 unit once weekly, for 6 weeks

vitamin C, oral tablet 1000 mg daily I, for 6 weeks

controls, Without intervention

vitamin E, oral capsule 400 mg daily I, for 6 weeks

Eligibility

Sex/Gender

All

Age

25 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: consciousness, ability to answer questions; That have not diabetic patients have complications from diabetes; almost three years Diagnosis them openly; aged 25 to 60. Exclusion criteria from the study: Unwillingness of the patient; not having kidney disease; Death.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Fast Blood Sugar. Timepoint: after intervention- before 6 weeks intervention. Method of measurement: forms.;Creatinine. Timepoint: after intervention- before 6 weeks intervention. Method of measurement: forms.;High density lipoprotein. Timepoint: after intervention- before 6 weeks intervention. Method of measurement: forms.;Triglyceride. Timepoint: after intervention- before 6 weeks intervention. Method of measurement: forms.;Low density lipoprotein. Timepoint: after intervention- before 6 weeks intervention. Method of measurement: forms.;Total Cholesterol. Timepoint: after intervention- before 6 weeks intervention. Method of measurement: forms.;2 Hours Post Prandial Blood Sugar. Timepoint: after intervention- before 6 weeks intervention. Method of measurement: forms.;Urine Analysis. Timepoint: after intervention- before 6 weeks intervention. Method of measurement: forms.;Blood Urea Nitorogen. Timepoint: after intervention- before 6 weeks intervention. Method of measurement: forms.	—

Measure

Time frame

Fast Blood Sugar. Timepoint: after intervention- before 6 weeks intervention. Method of measurement: forms.;Creatinine. Timepoint: after intervention- before 6 weeks intervention. Method of measurement: forms.;High density lipoprotein. Timepoint: after intervention- before 6 weeks intervention. Method of measurement: forms.;Triglyceride. Timepoint: after intervention- before 6 weeks intervention. Method of measurement: forms.;Low density lipoprotein. Timepoint: after intervention- before 6 weeks intervention. Method of measurement: forms.;Total Cholesterol. Timepoint: after intervention- before 6 weeks intervention. Method of measurement: forms.;2 Hours Post Prandial Blood Sugar. Timepoint: after intervention- before 6 weeks intervention. Method of measurement: forms.;Urine Analysis. Timepoint: after intervention- before 6 weeks intervention. Method of measurement: forms.;Blood Urea Nitorogen. Timepoint: after intervention- before 6 weeks intervention. Method of measurement: forms.

—

Secondary

Measure	Time frame
Renal failure. Timepoint: after of 6 weeks. Method of measurement: Urine Analysis, Creatinine, blood urea nitrogen.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamaneh Rezaei

Center for Diabetes Research? Kermanshah University of Medical Sciences

samanehrezaei1366@yahoo.com+98 38270662

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026